Nalaganje...

Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis with Alemtuzumab

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that remains difficult to treat. Even with current standard HLH therapy, only approximately half of patients will experience complete resolution of disease, and early mortality remains a significant...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Marsh, Rebecca A., Allen, Carl E., McClain, Kenneth L., Weinstein, Joanna L., Washko, Julie Kanter, Skiles, Jodi, Lee, Nadine D., Khan, Shakila P., Lawrence, Julia, Mo, Jun Q., Bleesing, Jack J., Filipovich, Alexandra H., Jordan, Michael B.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410971/
https://ncbi.nlm.nih.gov/pubmed/22522603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24188
Oznake: Označite
Brez oznak, prvi označite!